J&J beats third-quarter earnings expectations on higher prescription drug sales
October 15, 2019 at 06:47 AM EDT
J&J's pharmaceutical business, which accounts for half of the company's revenue, posted revenue of $10.88 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.